. "Appendix B: Agenda: Issues of Resistance: Microbes,Vectors, and the Host." The Resistance Phenomenon in Microbes and Infectious Disease Vectors: Implications for Human Health and Strategies for Containment -- Workshop Summary. Washington, DC: The National Academies Press, 2003.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
1:30
Resistance to HIV-1 Drug Therapies
Robert Redfield, The Institute of Human Virology, University of Maryland
2:00
Chloroquine-Resistant Malaria
Thomas Wellems, National Institute for Allergy and Infectious Diseases, NIH
2:30
Schistosomiasis and Antihelminth Resistance
Charles King, Division of Geographic Medicine, Case Western Reserve University
3:00
Epitope Escape Variants
Robert Webster, St. Jude Children’s Research Hospital and World Health Organization Collaborating Center for Studies on the Ecology of Influenza in Animals and Birds
Session II: Vector Resistance
Moderator: Barry Beaty, Colorado State University
3:30
Pesticide Resistance: Implications for Disease Emergence and Control
Janet Hemingway, Liverpool School of Tropical Medicine, United Kingdom
4:00
Studies in Antibiotic Resistance and Insecticide Resistance: Commonalties, Differences, and New Directions
Steven Peck, Zoology Department, Brigham Young University
4:30
Managing the Emergence of Pesticide Resistance in Disease Vectors
William Brogdon, Division of Parasitic Diseases, Centers for Disease Control and Prevention
Session III: Discussion Panel
Moderator: Carole Heilman, National Institute for Allergy and Infectious Diseases
5:00
William Jack, Georgetown University
Lynn Marks, GlaxoSmith Kline
Steve Brickner, Pfizer
6:00
Adjournment of the first day
6:15
DINNER MEETING OF THE FORUM ON EMERGING INFECTIONS
